- Home
- MDV vs ATRA Comparison
MDV vs ATRA Comparison
Compare MDV & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDV | ATRA |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.6M | 129.4M |
| IPO Year | 2022 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MDV | ATRA |
|---|---|---|
| Price | $14.45 | $17.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 35.1K | ★ 74.0K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | ★ 8.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.97 |
| Revenue | $47,479,000.00 | ★ $151,930,000.00 |
| Revenue This Year | $0.13 | N/A |
| Revenue Next Year | $0.71 | N/A |
| P/E Ratio | ★ N/A | $8.95 |
| Revenue Growth | N/A | ★ 51.27 |
| 52 Week Low | $13.62 | $5.01 |
| 52 Week High | $17.15 | $18.95 |
Technical Indicators
Market Signals| Indicator | MDV | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 44.84 | 62.68 |
| Support Level | $14.23 | $16.51 |
| Resistance Level | $14.81 | $18.95 |
| Average True Range (ATR) | 0.31 | 1.29 |
| MACD | -0.04 | 0.09 |
| Stochastic Oscillator | 25.28 | 72.07 |
Price Performance
Historical ComparisonAbout MDV Modiv Industrial Inc. Class C
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).